Əsas səhifə

Çap

Əks əlaqə

İnfo
Personalised risk communication for informed decision making about taking screening tests

Mündəricat

Personalised risk communication for informed decision making about taking screening tests

Sübutlu məlumatların xülasələri
17.07.2017 • Sonuncu dəyişiklik 17.07.2017
Editors

Personalised risk communication may have a small effect on increasing uptake of screening tests.

A Cochrane review included 22 studies. There was weak evidence, consistent with a small effect, that personalised risk communication (whether written, spoken or visually presented) increases uptake of screening tests (odds ratio [OR] 1.31, 95% confidence interval [CI] 0.98 to 1.77). More detailed personalised risk communication may be associated with a smaller increase in uptake of tests: for personalised risk communication which used and presented numerical calculations of risk, the OR for test uptake was 0.82 (95% CI 0.65 to 1.03). For risk estimates or calculations which were categorised into high, medium or low strata of risk, the OR was 1.42 (95% CI 1.07 to 1.89). For risk communication that simply listed personal risk factors the OR was 1.42 (95% CI 0.95 to 2.12).

Comment: The quality of evidence is downgraded by limitations in study quality (inadequate or unclear allocation concealment, inadequate intention-to-treat adherence) and by inconsistency (heterogeneity in interventions and outcomes).

Ədəbiyyat

  1. Edwards AG, Evans R, Dundon J, Haigh S, Hood K, Elwyn GJ. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev 2006 Oct 18;(4):CD001865.